ONS Congress | Oncology Nursing Society

Come together to commemorate oncology nursing’s rich history and be a part of the future of cancer care at the 50th Annual ONS Congress ®! Create a customized learning experience at ONS Congress. Choose from more than 70 sessions with educational tracks and session types to help you pinpoint the content that’s just right for you, no matter where you are in your career. ONS Congress is so more than top-notch education. You’ll be inspired by history and motivated by future possibilities. You’ll meet

Read the full article here

Source: www.ons.org

Categories: Oncologists1, General Medicine News

Tweets with this article

ONS

Take advantage of early-bird pricing when you register for the 50th Annual ONS Congress® by February 20, 2025. Save hundreds and register now: https://t.co/pjQIuLqkJS https://t.co/ehWhUJicmj

Related Articles

Elacestrant Shows Tolerability in Combination With CDK4/6, PI3K Inhibitors in Advanced ER+ Breast Cancer

Elacestrant was partnered with multiple targeted agents across varying dose levels and schedules for patients with estrogen receptor–positive advanced breast cancer.

OncLive.com December 27, 2024

Turning grief into purpose

Full of stamina and determination, Lynn Lippert supported others and did what she loved through 24 years of living with metastatic breast cancer. Lippert’s life…

Fred Hutch December 27, 2024

Healing Visual Arts Program Offers New Strategy for Artwork at Fox Chase Cancer Center and Network Locations

Art remains a vital part of Fox Chase Cancer Center’s culture. From the symbolic sculpture, The Diamond, greeting visitors outside the main entrance to the…

Fox Chase Cancer Center December 27, 2024

Enhanced Immunotherapy for Hodgkin Lymphoma : Oncology Times

An abstract is unavailable.

Oncology Times December 27, 2024

An Overview of the Treatment Landscape for Anemia Management in LR-MDS

Thomas W. LeBlanc, MD, MA, discusses how the standard of care (SOC) options for anemia management in patients with low-risk myelodysplastic syndromes (LR-MDS) typically involve…

Targeted Oncology December 27, 2024

Autologous HCT Does Not Provide Added Survival Benefit in Patients With MCL in First CR

Results of the EA4151/BMT-CTN 1601 trial showed similar progression-free and overall outcomes with the addition of autologous transplant to rituximab in mantle cell lymphoma.

OncLive.com December 27, 2024

What is the Whipple procedure? Explaining Randy Moss’ cancer surgery

Pancreatic cancer survival rates have more than doubled in the past decade. It’s not because of a single breakthrough, but better knowledge of the cancer,…

Fox Chase Cancer Center December 26, 2024

Axi-Cel Sustains Long-Term Efficacy in R/R Follicular Lymphoma and MZL

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

OncLive.com December 26, 2024

The year in cancer: 24 advances in 2024

By W. Kimryn Rathmell Director, National Cancer Institute Dr.

National Cancer Institute December 26, 2024

AACR-KidneyCAN Kidney Cancer Innovation and Discovery Grants

$50,000 over one year for researchers that seek to stimulate creative approaches to translate basic research into new treatment options for kidney cancer.

AACR December 26, 2024